AI Financial Corp (AIFC) KPIs and segments
Close on Nov 13, 2026Market cap $22.65MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive AI Financial's business
AI Financial's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fintech($M) | 5.51 | 5.42 | 4.94 | 2.17 | 0 | 0 | 0 | 0 | |||||
Corporate Segment and Other Operating Segment($M) | 0 | 0 | |||||||||||
Biotechnology($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Earlier reporting (last reported 2023)3 | |||||||||||||
Fintech($M) | -0.36 | 0.29 | 0.35 | 0.26 | 0 | 0 | 0 | 0 | |||||
Biotechnology($M) | -0.54 | 4.41 | -1.57 | -3.18 | -0.70 | 1.39 | -0.76 | -1.06 | -1.10 | -2.82 | 0.02 | -0.11 | |
Corporate Segment and Other Operating Segment($M) | -1.27 | -1.11 | |||||||||||
Earlier reporting (last reported 2023)3 | |||||||||||||
Fintech($M) | 2.59 | 2.84 | 2.36 | 1.10 | 0 | 0 | 0 | 0 | |||||
Corporate Segment and Other Operating Segment($M) | 0 | 0 | |||||||||||
Biotechnology($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Earlier reporting (last reported 2023)3 | |||||||||||||
Fintech($M) | -0.35 | -0.94 | 0.56 | 0.85 | 0 | 0 | 0 | 0 | |||||
Biotechnology($M) | -0.54 | 5.14 | -1.90 | -3.11 | -0.70 | -0.44 | -0.27 | 0.06 | -0.87 | 0.02 | -0.11 | ||
Corporate Segment and Other Operating Segment($M) | -1.69 | -1.52 | |||||||||||
Earlier reporting (last reported 2023)3 | |||||||||||||
Fintech($M) | 64.2 | 0 | |||||||||||
Biotechnology($M) | 16.9 | 17.8 | 29.2 | 0 | 0 | ||||||||
Corporate Segment and Other Operating Segment($M) | 1.29 | 0.64 | |||||||||||
Earlier reporting (last reported 2022)3 | |||||||||||||
Earlier reporting (last reported 2024)4 | |||||||||||||
6 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-04-13.
See a number that looks wrong?